5,6 Dihydro-5'-azacytidine (DHAC) restores androgen responsiveness in androgen-insensitive prostate cancer cells.
Year: 1999
Type: article
Source: PubMed
Authors: E Izbicka, J R MacDonald, K Davidson, R A Lawrence, L Gomez, D D Von Hoff
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2421239614